Puma Biotechnology, Inc.
Pharmaceutical company · Los Angeles, California, United States · Nasdaq: PBYI
Puma Biotechnology, Inc. is a pharmaceutical company headquartered in Los Angeles, California, United States. Its earliest recorded incorporation is in 2007. Its shares trade on Nasdaq under the ticker PBYI. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2011.
What does Puma Biotechnology do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $5 million sold (2011).
Frequently asked questions about Puma Biotechnology
Where is Puma Biotechnology headquartered?
Puma Biotechnology, Inc. is headquartered in Los Angeles, California, United States.
What does Puma Biotechnology do?
Puma Biotechnology, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Puma Biotechnology a public company?
Yes. Puma Biotechnology, Inc. trades on Nasdaq under the ticker PBYI.
When was Puma Biotechnology founded?
The earliest incorporation on record for Puma Biotechnology, Inc. is in 2007, according to public company registers.
Similar companies
- Niagen Bioscience, Inc.Los Angeles, California, United States
- Capricor IncLos Angeles, California, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.